erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rickettsia Infections D012282 5 associated lipids
Rickettsiaceae Infections D012288 2 associated lipids
Rosacea D012393 13 associated lipids
Rubella D012409 2 associated lipids
Salpingitis D012488 2 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Scarlet Fever D012541 1 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Sebaceous Gland Diseases D012625 1 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Seizures D012640 87 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Sialadenitis D012793 1 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Sinusitis D012852 9 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Skin Neoplasms D012878 12 associated lipids
Skin Ulcer D012883 6 associated lipids
Splenic Infarction D013159 1 associated lipids
Splenomegaly D013163 4 associated lipids
Sporotrichosis D013174 3 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Staphylococcal Scalded Skin Syndrome D013206 1 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Stomach Diseases D013272 7 associated lipids
Stomatitis D013280 14 associated lipids
Streptococcal Infections D013290 4 associated lipids
Surgical Wound Dehiscence D013529 3 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Synovitis D013585 15 associated lipids
Syphilis D013587 6 associated lipids
Syphilis, Cardiovascular D013589 1 associated lipids
Syphilis, Congenital D013590 3 associated lipids
Syphilis, Cutaneous D013591 1 associated lipids
Syphilis, Latent D013592 4 associated lipids
Tachycardia D013610 7 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Thromboembolism D013923 6 associated lipids
Thyroid Crisis D013958 1 associated lipids
Onychomycosis D014009 2 associated lipids
Tooth Diseases D014076 2 associated lipids
Tooth Fractures D014082 2 associated lipids
Tooth, Impacted D014095 9 associated lipids
Toothache D014098 3 associated lipids
Toxoplasmosis, Animal D014124 5 associated lipids
Tremor D014202 15 associated lipids
Trench Fever D014205 1 associated lipids
Trisomy D014314 6 associated lipids
Tuberculosis D014376 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Typhus, Epidemic Louse-Borne D014438 1 associated lipids
Uremia D014511 33 associated lipids
Urethral Diseases D014522 4 associated lipids
Urethritis D014526 9 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Urticaria D014581 13 associated lipids
Uveitis D014605 14 associated lipids
Varicose Ulcer D014647 4 associated lipids
Vibrio Infections D014735 5 associated lipids
Vomiting D014839 21 associated lipids
Vulvovaginitis D014848 2 associated lipids
Whooping Cough D014917 6 associated lipids
Wound Infection D014946 12 associated lipids
Wounds, Gunshot D014948 2 associated lipids
Xerostomia D014987 6 associated lipids
Yaws D015001 4 associated lipids
Superinfection D015163 3 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Scleritis D015423 3 associated lipids
Weight Gain D015430 101 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Granuloma, Respiratory Tract D015769 1 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Eye Infections, Parasitic D015822 2 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Torsades de Pointes D016171 2 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Bacteremia D016470 9 associated lipids
Foot Ulcer D016523 4 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Critical Illness D016638 13 associated lipids
Empyema, Pleural D016724 2 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ehrlichiosis D016873 2 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Chalazion D017043 1 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Skin Diseases, Viral D017193 2 associated lipids
Gastric Outlet Obstruction D017219 1 associated lipids
Skin Diseases, Papulosquamous D017444 2 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Blouin G et al. [Permanent elimination, by means of an acridine, of indicators of virulence and resistance to erythromycin in staphylococci]. 1965 Rev Can Biol pmid:5854942
Prado V et al. [Cryptosporidium enteritis in a leukemic patient]. 1985 Jul-Aug Rev Chil Pediatr pmid:3868787
Morice J et al. [Use of erythromycin ethyl succinate in acute infectious pictures of the respiratory system, eyes and skin]. 1970 Rev Chil Pediatr pmid:5470350
Bazán C and Saavedra R [Purulent meningitis in children under 2 years of age. Study of 65 cases from the Hospital del Niño (July 1962 to July 1964)]. 1966 Aug-Sep Rev Chil Pediatr pmid:5986917
BAZAN C et al. [Treatment of whooping cough with erythromycin]. 1953 Rev Chil Pediatr pmid:13134787
HARNECKER J et al. [PRELIMINARY CLINICAL-BACTERIOLOGICAL STUDY OF A NEW ANTIBIOTIC: LINCOMYCIN. TREATMENT OF 15 CASES OF DIPHTHERIA AS COMPARED TO 8 CASES TREATED WITH ERYTHROMYCIN]. 1963 Rev Chil Pediatr pmid:14090100
HARNECKER J et al. [COMMENTARIES ABOUT 16 PATIENTS WITH SCARLET FEVER TREATED WITH LINCOMYCIN. COMPARATIVE STUDY OF 5 CASES TREATED WITH ERYTHROMYCIN]. 1963 Rev Chil Pediatr pmid:14090101
González-Hein G et al. [Molecular analysis of fluoroquinolones and macrolides resistance in Campylobacter jejuni isolates from humans, bovine and chicken meat]. 2013 Rev Chilena Infectol pmid:23677151
Abarzúa F et al. [Streptococcus agalactiae increase in resistance to erythromycin and clindamycin in vaginal-anal colonization in third quarter of pregnancy in one decade of universal screening]. 2011 Rev Chilena Infectol pmid:22052397
Aguilera R C et al. [Antimicrobial susceptibility, capsular serotypes and clonal relationship of invasive streptococcus pneumoniae isolates in adult population of the Bio-Bio region, Chile. 2005-2006]. 2010 Rev Chilena Infectol pmid:21186502
Cofré Guerra J [Pertussis chemoprophylaxis: a sterile effort?]. 2006 Rev Chilena Infectol pmid:16462967
Abarzúa F et al. [Prevalence of anal-vaginal colonization of Streptococcus agalactiae in third trimester of pregnancy and susceptibility to macrolides and lincosamides, in pregnant women controlled at Clínica Alemana Temuco, Southern Chile]. 2014 Rev Chilena Infectol pmid:25146205
Tapia C et al. 2018 Rev Chilena Infectol pmid:29912257
Chirileanu C [Personal method of endotubal therapy]. 1978 Jul-Sep Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol pmid:151878
Suriñach JM et al. [Acute pancreatitis from erythromycin]. 1993 Rev Clin Esp pmid:8516513
Estrada V et al. [Red neck syndrome induced by erythromycin]. 1992 Rev Clin Esp pmid:1532860
Sanz Marca A et al. [Legionellosis. Apropos of a new sporadic case in our milieu]. 1982 Rev Clin Esp pmid:7089349
García Monzón C et al. [Cholestatic hepatitis caused by erythromycin estolate]. 1985 Rev Clin Esp pmid:3836470
Marti García JL et al. [Rheumatic pneumonitis]. 1975 Rev Clin Esp pmid:1135467
Segura-Corrales J et al. [Cat-scratch disease. Presentation of 2 cases in a family with serologic follow-up and discussion of diagnostic methods]. 1998 Rev Clin Esp pmid:9691742
Noya M and Del Río A [Antimicrobial therapy in ro cases of obstructive chronic bronchopneumopathy]. 1971 Rev Clin Esp pmid:5563102
García Buey L et al. [Hepatotoxicity of erythromycin]. 1989 Rev Clin Esp pmid:2785700
Pascual Velasco F [Mycoplasma pneumoniae pneumonia and pancreatitis]. 1990 Rev Clin Esp pmid:2091118
CORDERO FA [USE OF LAURYL SULFATE OF THE PROPIONIC ESTER OF ERYTHROMYCIN IN THE ORAL TREATMENT OF EARLY SYPHILIS AND OF CHANCROID]. 1963 Rev Col Med Guatem pmid:14125656
VELEZ MORAN C [Experience with erythromycin in the Hospital de Aislamiento de Guayaquil]. 1953 Rev Ecuat Hig Med Trop pmid:13237604
Rodríguez Cuartero A et al. [Acute hepatitis caused by erythromycin]. 1978 Rev Esp Enferm Apar Dig pmid:746229
Valerdiz Casasola S et al. [Hepatitis caused by drugs. 5]. 1982 Rev Esp Enferm Apar Dig pmid:6762631
LAFUENTEGUTIERREZ J [STAPHYLOCOCCAL SEPSIS WITH SEVERE ENTEROCOLITIS]. 1964 Rev Esp Enferm Apar Dig Nutr pmid:14151581
González Carro P et al. [Acute pancreatitis and erythromycin]. 1995 Rev Esp Enferm Dig pmid:8519548
Acea Nebril B et al. [Erythromycin: an alternative in conservative management of Ogilvie syndrome]. 1995 Rev Esp Enferm Dig pmid:7577132
Soler Dorda G et al. [Erythromycin: a useful alternative in the treatment of post-vagotomy gastroparesis]. 1994 Rev Esp Enferm Dig pmid:7848702
Moreno Sanz C et al. [Erythromycin and prolonged postoperative paralytic ileus]. 1994 Rev Esp Enferm Dig pmid:7766243
Charco Torra R et al. [Usefulness of erythromycin in severe postoperative gastroparesis]. 1994 Rev Esp Enferm Dig pmid:8186001
BARON J [Erythromycin]. 1954 Jul-Aug Rev Esp Pediatr pmid:13225049
CARBONELL JUANICO M et al. [COMMENTARIES ABOUT STAPHYLOCOCCAL PNEUMOPATHIES IN THE INFANT. (REPORT OF 61 CASES)]. 1963 Nov-Dec Rev Esp Pediatr pmid:14110085
Gordillo RM et al. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)]. 2003 Rev Esp Quimioter pmid:12750758
Rodríguez-Zurita ME et al. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain]. 2003 Rev Esp Quimioter pmid:12750759
Campelo FA et al. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)]. 2012 Rev Esp Quimioter pmid:22488541
Calle-Miguel L et al. [Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)]. 2017 Rev Esp Quimioter pmid:28233483
Bellido JL et al. [Resistance to macrolides in Streptococcus pyogenes]. 1998 Rev Esp Quimioter pmid:9795305
Limia A et al. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. 1998 Rev Esp Quimioter pmid:9795307
Correa AM et al. [Pneumococcal bacteremia in adult patients at a hospital in Madrid: serotypes and susceptibility]. 2012 Rev Esp Quimioter pmid:22707105
Rodríguez-Avial I et al. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin]. 2001 Rev Esp Quimioter pmid:11856983
Rodríguez-Avial C et al. [Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures]. 2001 Rev Esp Quimioter pmid:11753449
González-Abad MJ and Alonso-Sanz M [Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia]. 2013 Rev Esp Quimioter pmid:23817644
Sanz-Rodríguez N et al. [Accuracy of Etest method to study Campylobacter spp. susceptibility to erythromycin, ciprofloxacin and tetracycline]. 2013 Rev Esp Quimioter pmid:23817649
Arana DM et al. First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu(B) gene. 2014 Rev Esp Quimioter pmid:24940891
Granizo Martínez JJ [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides]. 2005 Rev Esp Quimioter pmid:15915241
CANAVOSIO AE et al. [THERAPEUTIC CONSIDERATIONS ABOUT ANTHRAX]. 1964 Jan-Mar Rev Fac Cienc Med Cordoba pmid:14184421
CRISCUOLO E et al. [Erythromycin in the treatment of acute brucellosis]. 1955 Jan-Mar Rev Fac Cienc Med Cordoba pmid:14395772
ALBORNOZ PLATA A [Erythromycin-carbarsone in the treatment of amebiasis]. 1959 Oct-Dec Rev Fac Med Univ Nac Colomb pmid:13792418
VINCENDEAU J Propiocine in the aged person. Experience of a winter 1961 Rev Fr Gerontol pmid:13926063
Couvreur J et al. [Chlamydia trachomatis pneumopathies in infants]. 1984 Rev Fr Gynecol Obstet pmid:6528159
Nguyen J et al. [Results of antibiotic sensitivity and "Streptococcus pneumoniae" serotype tests in the Pitié-Salpêtrière hospital, France, 1979-1980 (author's transl)]. 1982 Rev Fr Mal Respir pmid:7100613
Valeyre D et al. [Legionnaires disease : 3 cases from the northern suburbs of Paris (author's transl)]. 1981 Rev Fr Mal Respir pmid:7302345
Merklen FP and Renoux M [Antibiotics other than penicillin in the treatment of syphilis]. 1967 Rev Fr Odontostomatol pmid:5235420
Cernea P and Devien CV [Therapeutic value of a new comined antibiotic therapy]. 1967 Rev Fr Odontostomatol pmid:5238749
Belluzzo UB [Use of erythromycin in preoperative treatment of extractions for periapical abscess]. 1970 Jan-Mar Rev Gaucha Odontol pmid:5270108
Miniti A et al. [Comparative study of doxycycline and erythromycin concentrations in the palatine tonsils]. 1970 Nov-Dec Rev Hosp Clin Fac Med Sao Paulo pmid:5496438
Souza R et al. Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. 2002 Jul-Aug Rev Hosp Clin Fac Med Sao Paulo pmid:12244337
Elias A [Prevention of streptococcal infections and post-streptococcal complications]. 1979 Jul-Sep Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol pmid:504884
Ispas LT and Popescu CM [Legionellosis]. 1984 Oct-Dec Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol pmid:6097987
MENDEZ D and MARIN G [Erythromycin in the treatment of diphtheria]. 1955 Rev Inst Salubr Enferm Trop pmid:13336727
LEON AP [Ilotycin in therapy of diphtheria and of carriers of Corynebacterium diphtheriae]. 1954 Rev Inst Salubr Enferm Trop pmid:13225071
LEON AP and CANO C [Effect of ilotycin on Brucella and its use with streptomycin in therapy of human brucellosis]. 1954 Rev Inst Salubr Enferm Trop pmid:13225072
LEVRAT M et al. [THE BILIARY ELIMINATION OF ANTIBIOTICS]. 1964 Rev Int Hepatol pmid:14156362
RAIS H [First attempts at treatment of trachoma with erythromycin]. 1955 Rev Int Trach pmid:13311128
NATAF R et al. [COMPARATIVE STUDY OF THE ACTION OF ERYTHROMYCIN AND CHLORTETRACYCLINE (AUREOMYCIN) IN THE TREATMENT OF TRACHOMA]. 1965 Rev Int Trach pmid:14304523
NATAF R et al. [COMPARATIVE STUDY OF THE EFFECTS OF ERYTHROMYCIN AND CHLORTETRACYCLINE (AUREOMYCIN) IN THE TREATMENT OF TRACHOMA]. 1963 Rev Int Trach pmid:14208068
Whitcher JP et al. [Severe endemic trachoma in Tunisia: changes in ocular bacterial pathogens in children treated by the intermittent antibiotic regimen]. 1974 Rev Int Trach pmid:4157128
Tarizzo ML and Nataf R The treatment of trachoma. 1969-1970 Rev Int Trach pmid:5406193
PANNARALE MR [Results of erythromycin treatment of trachoma; clinical and microbiological research]. 1955 Rev Int Trach pmid:14395964
Molina Pasquel C et al. [Treatment of intestinal amebiasis using erythromycin stearate of normal release with enteric coating (A-16535). Study of 13 cases. Preliminary report]. 1967 Oct-Dec Rev Invest Salud Publica pmid:5618959
MEYER J and KIEFFER L [Study of the bacteriostatic action in vitro of an erythromycin propionate-sulfonamide association on pathogenic staphylococci]. 1960 Oct-Dec Rev Kuba Med Trop Parasitol pmid:24545883
Nguyen J et al. [Evolution of the resistance of Streptococcus pneumoniae to erythromycin at the Pitié-Salpêtrière Hospital (1980-1984)]. 1986 Rev Mal Respir pmid:3809698
Hajji M and Himmich H [True acute lobar pneumococcal pneumonia. Apropos of 51 cases]. 1985 Rev Mal Respir pmid:3835611
Campbell DB et al. Pharmacodynamic and pharmacokinetic interactions of almitrine bismesylate. 1985 Rev Mal Respir pmid:2870546
Carré P et al. [The in vivo penetration of erythromycin into alveolar macrophages]. 1990 Rev Mal Respir pmid:2320782
Chiappini J et al. [Subacute idiopathic eosinophilic pneumopathy with favorable outcome without corticotherapy]. 1995 Rev Mal Respir pmid:7899663
Courbot A et al. [Sinobronchial syndrome]. 2001 Rev Mal Respir pmid:11424716
Rodríguez C et al. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period]. 2011 Rev Med Chil pmid:22215392
CASTELLON M and PRATS F [Ilotycin (erythromycin) in the treatment of recent syphilis; preliminary experience]. 1956 Rev Med Chil pmid:13371006
Soler T et al. [In vitro susceptibility of streptococcus pneumoniae strains isolated from lower respiratory infections in Instituto Nacional del Tórax (INT)]. 2002 Rev Med Chil pmid:12043373
Prado V et al. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains]. 1993 Rev Med Chil pmid:8191116
DOONER H et al. [Treatment of staphylococcal infections with erythromycin propionate]. 1960 Rev Med Chil pmid:13723831
Martini J et al. [Treatment of acute male gonococcal urethritis with a single dosis of erythromycin-stearate]. 1968 Rev Med Chil pmid:5746282
Juliet C et al. [Sensitivity of Streptococcus pneumonias and its clinical importance]. 1987 Rev Med Chil pmid:3506278
Fernández H and Toledo G [In vitro susceptibility of Clostridium perfringens to 6 antimicrobial agents]. 1982 Rev Med Chil pmid:6306749
Martínez MA et al. [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae]. 2004 Rev Med Chil pmid:15279140
Martinez MA and Pinto ME [Antimicrobial sensitivity of Ureaplasma urealyticum in vitro]. 1985 Rev Med Chil pmid:2940655
Turcu T [Group A Streptococcus and penicillin G today]. 1977 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:349648
Dimitriu S ["Legionnaires disease"]. 1978 Jul-Sep Rev Med Chir Soc Med Nat Iasi pmid:16296493
Teodorovici G et al. [Evolution of the antibiotic sensitivity of pathogenic staphylococci isolated in rural areas]. 1967 Jul-Sep Rev Med Chir Soc Med Nat Iasi pmid:5195743
Popovici I et al. [Eritroacnol--an emulsion for the treatment of pyoderma]. 1988 Jul-Sep Rev Med Chir Soc Med Nat Iasi pmid:3249873
Poiată A et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from colonized hospital personnel. 2006 Jul-Sep Rev Med Chir Soc Med Nat Iasi pmid:17571573
Bancescu G et al. Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics. 2006 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:17438917
Mihul V et al. [Staphylococcal epiduritis. Clinico-therapeutic considerations (7 cases)]. 1974 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:4453714
Oniscu C et al. [Methods of advanced purification-the challenge for biosynthetic antibiotics industry]. 2002 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:12638304
Galaction AI et al. [Separation of erythromycin by direct pertraction from simulated broths]. 2009 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:21495378
Cojocaru I et al. [Dermatologic preparations with erythromycin--the correlation of the pharmaceutical form-therapeutic effect]. 1997 Jul-Dec Rev Med Chir Soc Med Nat Iasi pmid:10756791